Future Cannabis Strategies Europe 2020
Royal Lancaster London
29th-30th January, 2020
Preview The Agenda
Future Cannabis Strategies Europe 2020
Future Cannabis Strategies brings together business leaders from across the wider European Consumer-Facing Cannabis products category for 2 days of insight, discussion and debate into how cannabis product manufacturers can understand:
- Consumer trends & demands from European cannabis derived product consumers
- Opportunities to introduce Cannabis/ Hemp infused products into existing FMCG product portfolios
- Recent product innovation to understand how market trends are adapting
- Up to date regulatory advice for manufacturers and retailers across Europe
- International market opportunities
WHAT TO EXPECT
Future Cannabis Strategies Europe brings together strategic business leaders from across Europe’s Consumer-Facing Cannabis products category, this includes CBD/ Cannabis Products & Devices, Beverages, Tobacco, Cosmetics & Nutraceuticals.
350+
ATTENDEES TO MEET EACH YEAR
25+
EXHIBITORS TO MEET EACH YEAR
25+
KEYNOTE PRESENTERS
80%
ATTENDEES AT DIRECTOR + LEVEL
Why Attend
FEEDBACK FROM 2019'S EVENT
-
We launched the Future Cannabis Strategies series in January 2019 in London. The launch event was an overwhelming success with over 275 senior executives descending on The Chelsea Harbour for 2 days of thought-provoking presentations, hours of networking and exclusive insights from industry leaders from around the world. 2020 will see the event come back bigger and better – do not miss the chance to get involved
-
“Highly Informative”
“I felt the conference was well run with interesting speakers”
“Done very well”
“Very positive. Met some very helpful people”
“Good content. Friendly organisers”
“Very informative with good networking opportunities”
-
“Diverse range of participants”
“Generally good organizational standard, relevant presentations and good networking opportunities”
“Enlightening. A truly revolutionary view of an emerging market”
“Incredibly useful and a key source of information, especially regulatory developments”
“Great mix of people and companies”
“Interesting topics”
WHO SHOULD ATTEND?
-
Delving into key issues to be considered when building and developing a Cannabis derived product, the 2020 conference agenda is designed for senior executives responsible for New Product Development, Consumer Insights, Research & Development, Commercial Strategy, from:
-
FMCG brands
Start-up & SME brands leading the way in cannabinoid product development (example sectors: Beverages, Cosmetics & Nutraceuticals)
Alternative Health/ Natural Remedy retailers & manufacturers
Consumer, OTC & Animal Health product manufacturers
Tobacco & E-liquid manufacturers
Policy makers, regulatory bodies and public health
Service providers to the industry
-
This event provides an unrivalled platform for networking with key decision-makers alongside offering a unique opportunity to learn from and meet with respected industry professionals. We have created a unique platform bringing together strategy, product development and sector strategists to deliver a 360° view on the opportunity to develop CBD/ Cannabis infused consumer FMCG products.
ARENA INTERNATIONAL
-
Arena International Events Group is welcomes over 10,000 business executives each year who attend over 80 of our events worldwide, they are addressed by over 1700 industry leaders delivering leading edge content and discussion.
Arena International’s events consistently strive to provide thought-provoking content and unrivalled networking opportunities. But, don’t take our word for it, below is some previous event feedback we received in the past 12 months!
-
‘Excellent networking event, very informative and a great insight into the future of the industry’
‘A great opportunity to meet industry leaders and widen our network in a growing industry sector’
‘Excellent source of information’
-
‘Very informative. A great opportunity for networking and discussing views on the future industry challenges we face’
‘An excellent opportunity to meet with current and prospective new clients’
‘Enlightening, educational, and gained insight into the bigger picture’

Paul Gurney
Managing Director, Equity Sales Europe & Asia Pacific,BMO Capital Markets
Biography: Paul Gurney is a Managing Director at BMO Capital Markets in London, UK, leading BMO’s coverage of large institutional equity clients in Europe and Asia Pacific. Paul has 15 years of capital markets experience, researching companies, syndicating transactions, structuring deals, and providing value-added advice to institutional and corporate clients across multiple sectors. In early 2018, Bank of Montreal (BMO) became the first major bank to underwrite the cannabis sector, leading a US$175m equity financing for the world’s largest cannabis company, Canopy Growth. Paul has been closely involved in the sector in Europe ever since, helping raise US$153m for Tilray, the first ever NASDAQ listed cannabis company, and the third best performing IPO in the US in 2018. Paul spearheads BMO’s investment efforts for cannabis companies in Europe, and Australia, introducing investors to sector heavyweights like Aphria, Aurora, Canopy Growth and Tilray, while actively developing the next generation of pre-IPO cannabis companies. Paul’s early involvement in the sector has helped him develop a deep network of industry and client contacts, making him one of the thought leaders for the sector in Europe.
Session Details: Keynote: The Green Gold Rush! Expectations For Global Cannabis & Hemp Stocks 29-01-2020, 10:30 am View In Agenda

Catherine Wilson
Managing Director & Board Member,CannaWellness & European Industrial Hemp Association

Tej Virk
President,Khiron Europe GmbH
Biography: Former Deputy Managing Director for Canopy Growth Germany, leading the international expansion of the company across European markets
Session Details: Industry Panel: International Markets In Focus 30-01-2020, 2:55 pm View In Agenda

Dr Thierry Kern
Regulatory Affairs Specialist,PenTec Consulting
Biography: Dr Thierry Kern is a regulatory manager with experience in the development of new medicines and interacting with regulatory authorities worldwide for medicine approvals. He holds a Pharm.D. in pharmaceutical clinical development from the University of Pharmacy of Strasbourg, France, and a postgraduate diploma in environmental epidemiology from the University of Medicine of Grenoble in France. Thierry has worked in the UK and the USA, managing regulatory, pharmacovigilance, inspection readiness teams and registration procedures for medicines with the EU Authorities and the FDA. Thierry also worked for the European Medicines Agency managing referral procedures and updates to the good pharmacovigilance practices regulation. Thierry joined Pen & Tec in 2018 and specialises in feed and food registration projects in the EU, ensuring scientific and regulatory excellence in the work that Pen & Tec delivers.
Session Details: Novel Food Standards Panel: Testing, Compliance and Restrictions 30-01-2020, 9:20 am View In Agenda

,

Andrew Fuller
Technical Director,BridgeFarm Group
Biography: Andrew has had a long-term passion for horticulture, obtaining a degree in Commercial Horticulture, holding seat as chairman of the British Bedding and Pot Plant Association Technical Committee and sitting on the AHDB Protected Ornamentals Panel committee. Andrew joined Neame Lea in 2014 as Growing and Production Manager, overseeing the planning and scheduling of a range of crops to meet customer expectations and has since become Bridge Farm Group’s head of growing.
Session Details: Growers Panel: Hemp Farming In Europe 30-01-2020, 10:00 am View In Agenda

Nathaniel Loxley
Director,British Hemp Alliance
Biography:
Session Details: Growers Panel: Hemp Farming In Europe 30-01-2020, 10:00 am View In Agenda

Peter Shippen
CEO,Britania Bud
Biography:
Session Details: Growers Panel: Hemp Farming In Europe 30-01-2020, 10:00 am View In Agenda

Colleen Quinn
Founder & Director,LabAroma & Colleen Quinn Consultancy
Biography:
Session Details: Industry Panel: International Markets In Focus 30-01-2020, 2:55 pm View In Agenda

Boris Blatnik
CEO,KannaSwiss AG
Biography: Boris serves as CEO of KannaSwiss. He joined the team January of 2017 and has been instrumental in the rebranding and business development of the company. Prior to KannaSwiss Boris served as CSO and Co-founder of Numbridge Inc. from 2009 until 2016. Numbridge was a telecommunication app that helped people communicate over the GSM network. Boris served as CEO & Co-founder of Atlas Commercial Holdings from 2004 until 2009. Atlas established an interlocking network of global business alliances and partnerships to provide customized solutions that enable governments and local businesses in emerging markets to stabilize and upgrade their basic infrastructures. Formerly he was Founder & President of V Karting, an integrated go-kart facility with conference rooms, restaurant and entertainment/game space. His experiences range from construction to telecommunications to natural resource consulting working with such companies as MAN Ferrostaal and Petrobras. Boris earned his A-levels from Aiglon College in Villars, Switzerland and then attended American University in Washington, DC. Born in Caracas, Venezuela, Boris was raised in Switzerland and moved to the U.S. to attend university. He is fluent in English, Spanish, French, German, Italian, and Portuguese.
Session Details: Industry Panel: International Markets In Focus 30-01-2020, 2:55 pm View In Agenda

Jonas Duclos
CEO,CBD420 by JKB Research SA
Biography:
Session Details: Industry Panel: International Markets In Focus 30-01-2020, 2:55 pm Incorporating Sustainable & Community Values To Build A Successful Cannabis Brand 30-01-2020, 3:40 pm View In Agenda

Daniel Khoury
Co-Founder,TRIP
Biography:
Session Details: Keynote: Beverages In Focus – TRIP Case Study 29-01-2020, 12:50 pm View In Agenda

,

Rebekah Hall
CEO,South West Brands Ltd
Biography:
Session Details: Innovation Keynote: Cannabis 2.0 The Botanic Lab Way 29-01-2020, 2:20 pm View In Agenda

Dr Colin Morgan
Business Development Director,ADAS
Biography:
Colin is a Business Development Director at ADAS. ADAS https://www.adas.uk/ is a well-established agricultural and environmental services consultancy owned by the UK’s largest independent environmental consultancy - RSK Group https://rskgroup.com/. ADAS provides ideas, specialist knowledge and solutions to secure our food and enhance the environment and has specialisms across agriculture for the production of sustainable value chains for food, fuel and fibre.
Colin works across sustainable agriculture and is also the lead for the ADAS Cannabis Value Chain Services Portfolio. ADAS did a landmark piece of work in cannabis as long ago as 2004 and has recently positioned itself as the leading independent organisation that can work to integrate cannabis crops for the contribution to sustainable development – based on our trusted position in the sector.
Colin has also worked for global certification bodies and global transparent food chain programmes and combines this knowledge with the ADAS team’s extensive knowledge of agriculture and environment to provide solutions for the legal cannabis sector in environmental consultancy, standards development, building transparent and ethical value chains, research in to higher performing crops and policy development.
Session Details: Growers Panel: Hemp Farming In Europe 30-01-2020, 10:00 am View In Agenda

Nick Clarkson
Director,Phytovista Labs
Biography:
Session Details: Cannabis and CBD Product Testing in the UK 29-01-2020, 4:40 pm View In Agenda

Grégoire Audo
Director of Purification Services ,Gilson
Biography: Grégoire Audo received his Master Degree in “Natural product purification and identification” from Reims University in France in 2000 and his MBA in Nantes in 2002. Since that time he focus his career to develop CPC/CCC techniques in all aspects in different companies. In particular he works in collaboration with few research groups and gave conferences worldwide to enhance the visibility of this technology. He is now working at Gilson as director of purification services
Session Details: Cost effective & scalable solutions for production of pure cannabinoids & broad-spectrum cannabinoids oil 30-01-2020, 2:25 pm View In Agenda

Richard Hodgson
Pharmaceutical Market Specialist,Shimadzu
Biography: Richard Hodgson has extensive experience with liquid chromatography since gaining his Ph.D. in Chemistry and subsequent academic research positions. A decade of experience with LC applications has led to his current position at Shimadzu UK Ltd as a Pharmaceutical Market Specialist. Whilst this role covers a wide range of responsibilities Richard is still keen on hands on laboratory analysis and is part of a team developing novel market driven applications and solutions.
Session Details: Cannabinoid Analysis in Finished Products 29-01-2020, 3:20 pm View In Agenda

Frederik Hendriksen
VP International Sales and Business Development,Mile High Labs
Biography: Frederik Hendriksen is VP of International Sales & Business Development at Mile High Labs. He grew up in a small town in north western Denmark, moving to Copenhagen Business School for his bachelor’s and master’s degrees. During this time he took the opportunity to work in Japan, China, Zambia and London, where he settled in 2014. He joined Morgan Stanley doing Equity Trading and M&A, fast tracking to Vice President and being selected for the most prestigious talent programme MS offers. Fred resigned from his banking job in early 2019 to join Mile High Labs, the world's leading CBD extractor, building and managing sales for all non-US markets. The company is leading the way in ensuring compliance within the current regulatory framework. MHL is also investing heavily in R&D, working closely with a range of top universities to ensure the highest standards of consumer safety and develop a range of new products.
Session Details: The commercial opportunity for CBD in Europe 29-01-2020, 11:35 am View In Agenda

Professor Robert Somogyi
Chief Commercial Officer,RotaChrom
Biography: Prof. Robert Somogyi is the Chief Commercial Officer at RotaChrom Technologies, he leads the Commercial department to give a boost to the fame of an exclusive Hungarian product and lead the commercial operation of this unique corporation. He has joined the company 3 years ago with a strong professional background in the health care industry, global business development and brand management. Professor Somogyi has several-year-long experience in management consultancy as he liaised with leading German companies representing various industries. He has also spent more than ten years as a Commercial Director at a Worldwide-known Premium brand. Following this, he joined the health care industry, he worked for a worldwide operating health care Swiss company as CEO. He stayed attached to the health-care industry as he created his own company dealing with premium air purification solutions. In the last couple of years, Prof. Somogyi has set his extended professional knowledge in the service of bringing pharma-grade certification to the cannabis industry. Since the growth of the cannabis market is strictly related to the health care, Mr. Somogyi is actively involved in the global market development as a C level expert.
Session Details: Game-changer in the world of refining processes – future of the industry with consistent high quality end product 29-01-2020, 4:00 pm View In Agenda

Andrea Properzi
QM,Fundacion CANNA
Biography:
Session Details: Novel Food Standards Panel: Testing, Compliance and Restrictions 30-01-2020, 9:20 am Industry Panel: International Markets In Focus 30-01-2020, 2:55 pm View In Agenda

Tim Phillips
Managing Director,CBD-Intel
Biography:
Session Details: Is CBD A Passing Fad? 29-01-2020, 4:20 pm Industry Panel: International Markets In Focus 30-01-2020, 2:55 pm View In Agenda

Dr Colin Morgan
Business Development Director,ADAS
Biography:
Colin is a Business Development Director at ADAS. ADAS https://www.adas.uk/ is a well-established agricultural and environmental services consultancy owned by the UK’s largest independent environmental consultancy - RSK Group https://rskgroup.com/. ADAS provides ideas, specialist knowledge and solutions to secure our food and enhance the environment and has specialisms across agriculture for the production of sustainable value chains for food, fuel and fibre.
Colin works across sustainable agriculture and is also the lead for the ADAS Cannabis Value Chain Services Portfolio. ADAS did a landmark piece of work in cannabis as long ago as 2004 and has recently positioned itself as the leading independent organisation that can work to integrate cannabis crops for the contribution to sustainable development – based on our trusted position in the sector.
Colin has also worked for global certification bodies and global transparent food chain programmes and combines this knowledge with the ADAS team’s extensive knowledge of agriculture and environment to provide solutions for the legal cannabis sector in environmental consultancy, standards development, building transparent and ethical value chains, research in to higher performing crops and policy development.
Session Details: Growers Panel: Hemp Farming In Europe 30-01-2020, 10:00 am View In Agenda

Dr Julie Moltke
Editor in Chief,Dosage Magazine
Biography: Dr Julie Moltke is a medical doctor and has spent most of her career focusing on mental health, stress management, and the medicinal cannabis industry. She believes in personalised medicine and seeing every client as an individual with a holistic approach to health and wellbeing. She is the scientific advisor for Thedrug.store and the founder of the London-based health, wellness and cannabis science publication, Getthedose. Dr Julie prescribes medicinal cannabis at Clinic Horsted in Denmark and she is a public speaker and a yoga and mindfulness teacher. She also owns and runs a retreat centre at her farm in southern Sweden.
Session Details: How CBD is disrupting the way we look at health and standard treatment 30-01-2020, 10:40 am View In Agenda

Franziska Katterbach
Managing Director & Chief Legal Officer,Khiron Europe GmbH
Biography:
- Former Dentons lawyer and Director of Legal at Canopy Growth Germany, starting as external counsel and later joining the company, executing Canopy Growth’s M&A strategy
- Experienced with the European cannabis regulatory and legal landscape since 2016
Session Details: Novel Food Standards Panel: Testing, Compliance and Restrictions 30-01-2020, 9:20 am View In Agenda

Gabriel Sapir
Senior Consultant, Life Sciences and Biotechnology,GlobalData
Biography: Gabriel is a Senior Consultant at GlobalData. Having trained in clinical medicine, he was a William J. Harrington Scholar for Latin America at the University of Miami (Jackson Memorial Hospital) and a Marie Curie Fellow at the University of Newcastle (National Health Service Blood and Transplant), where he completed his Fellowship in Immunology and Organ Transplantation. He holds a Master’s degree from the University of Oxford in Global Health Sciences and Health Economics. He has worked 5+ years in Life Sciences R&D consulting performing due diligence for financial investments with a portfolio of US$ 250 million in completed deals and acceleration of various products and start-ups across the EMEA region. He holds Israeli, British and Brazilian citizenships and speaks English, Portuguese, Spanish, and German fluently. I get asked to talk about investments, strategic, commercial and industrial solutions in Biotechnology and Life Sciences. As a consultant, I offer my capability to sit on the same table with R&D, Commercial, Clinical and translational professionals, and entrepreneurs and start-ups in various development stages. With knowledge of the financial world, I liaise with venture Capitalists, Institutional investors and financial analyst so to strike partnerships and deals to accelerate products, generate strategic and commercial partnerships and accelerate products to commercialisation. Additional skills include product market forecast, due diligence and data analytics insights.
Session Details: Keynote: Harnessing The Global Cannabinoid Opportunity 29-01-2020, 9:30 am Novel Food Standards Panel: Testing, Compliance and Restrictions 30-01-2020, 9:20 am View In Agenda

Calin Coman
Regional Director, Europe,New Frontier Data
Biography: Calin Coman is Regional Director, Europe for New Frontier Data, where he oversees New Frontier Data's commercial strategy, research, and partnerships within Europe. New Frontier Data, the authority in data, analytics, and business intelligence for the cannabis industry, is an independent technology company whose mission is to elevate the discussion around the legal cannabis industry globally by providing unbiased vetted information and educating stakeholders to make informed decisions. Previously, Calin served as Chief Investment Officer for Canalis Capital, a Panama based cannabis venture capital and acceleration firm. Prior to his time in cannabis, Calin spent several years in the commodities trading sector where he managed cross-asset portfolios in agricultural physical commodities, derivatives and foreign exchange. He is a CFA charter holder and has also held positions in risk management and finance.
Session Details: Capturing the New CBD Consumer 29-01-2020, 2:50 pm View In Agenda

Gary Allen
COO,New Frontier Data
Biography:
Session Details: Capturing the New CBD Consumer 29-01-2020, 2:50 pm View In Agenda

Brett Vye
Former CEO,Truss Beverages
Biography:
Session Details: Keynote: Launch & growth of consumer cannabis beverage brands, the need to know 29-01-2020, 10:00 am View In Agenda
Sponsors























Bibra
SPONSORSHIP OPPORTUNITIES
If you have a service or product you would like to showcase, please contact:
Ben Lloyd-Davies
Head of Business Development
E-mail: BenLloyd-Davies@arena-international.com
Telephone: +44 (0)207 936 6552
SPEAKER OPPORTUNITIES
If you have any unique case studies or topics you would like to see covered on the agenda please contact:
David Jones
Programme Manager
E-mail: David.Jones@arena-international.com
Telephone: +44 (0)207 936 6645